VENLAFAXINE ARROW GENERIQUES LP 75 mg, extended-release capsule 50 capsules
Active ingredients: Venlafaxine hydrochloride, Venlafaxine
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Extended-release capsule50 capsulesorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- VENLAFAXINE ARROW GENERIQUES LP 75 mg, gélule à libération prolongée
- Pharmaceutical form
- gélule à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium de 50 gélule(s)
- Marketing authorisation holder
- ARROW GENERIQUES
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 May 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64959295CIP73009152CIP133400930091524Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE VENLAFAXINEgélule | — | SA |
| VENLAFAXINEgélule | 75 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.